Olaf Anders

403 total citations
9 papers, 321 citations indexed

About

Olaf Anders is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Olaf Anders has authored 9 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Surgery. Recurrent topics in Olaf Anders's work include Blood properties and coagulation (3 papers), Platelet Disorders and Treatments (3 papers) and Blood Coagulation and Thrombosis Mechanisms (2 papers). Olaf Anders is often cited by papers focused on Blood properties and coagulation (3 papers), Platelet Disorders and Treatments (3 papers) and Blood Coagulation and Thrombosis Mechanisms (2 papers). Olaf Anders collaborates with scholars based in Germany, Sweden and Switzerland. Olaf Anders's co-authors include Minoru Okuma, Richard W. Farndale, Kenneth J. Clemetson, Beate E. Kehrel, Christopher G. Knight, Michael J. Barnes, Michael Steiner, Dagmar Barz, Michael Steiner and Hansjörg Thude and has published in prestigious journals such as Blood, Thrombosis Research and Vox Sanguinis.

In The Last Decade

Olaf Anders

9 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olaf Anders Germany 5 233 95 87 68 48 9 321
Nancy Cauwenberghs Belgium 5 284 1.2× 46 0.5× 40 0.5× 108 1.6× 85 1.8× 7 341
Taavo Tenno Sweden 8 173 0.7× 32 0.3× 59 0.7× 90 1.3× 53 1.1× 11 363
Akinobu Funatsu Japan 11 263 1.1× 31 0.3× 27 0.3× 69 1.0× 57 1.2× 22 354
Henk Louwes Netherlands 8 358 1.5× 85 0.9× 17 0.2× 44 0.6× 28 0.6× 14 448
Béatrice Saposnik France 6 265 1.1× 34 0.4× 27 0.3× 75 1.1× 18 0.4× 8 332
Nathalie Valentin France 10 369 1.6× 64 0.7× 144 1.7× 15 0.2× 87 1.8× 16 528
Inge Scharrer Germany 6 239 1.0× 63 0.7× 18 0.2× 70 1.0× 26 0.5× 8 344
Verónica Palma‐Barqueros Spain 10 212 0.9× 40 0.4× 17 0.2× 30 0.4× 19 0.4× 15 288
Seb Lamprecht Belgium 9 321 1.4× 27 0.3× 22 0.3× 101 1.5× 58 1.2× 12 497
C Tommasino Italy 7 96 0.4× 21 0.2× 33 0.4× 16 0.2× 26 0.5× 11 251

Countries citing papers authored by Olaf Anders

Since Specialization
Citations

This map shows the geographic impact of Olaf Anders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olaf Anders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olaf Anders more than expected).

Fields of papers citing papers by Olaf Anders

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olaf Anders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olaf Anders. The network helps show where Olaf Anders may publish in the future.

Co-authorship network of co-authors of Olaf Anders

This figure shows the co-authorship network connecting the top 25 collaborators of Olaf Anders. A scholar is included among the top collaborators of Olaf Anders based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olaf Anders. Olaf Anders is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Schäffler, Holger, et al.. (2017). Vedolizumab Treatment for Ulcerative Colitis in an Elderly Multimorbid Patient with Hemophilia A. Case Reports in Gastroenterology. 11(3). 774–779. 1 indexed citations
2.
Thude, Hansjörg, et al.. (2002). Analysis of the thrombomodulin gene in patients with venous thrombosis. Thrombosis Research. 107(3-4). 109–114. 4 indexed citations
3.
4.
5.
6.
Pilger, Ernst, Henry Eriksson, Kurt Grüngreiff, et al.. (1996). Multicenter studies of ultra-high-dose, short-duration streptokinase treatment of deep vein thrombosis. Current Therapeutic Research. 57(4). 251–267. 2 indexed citations
7.
Anders, Olaf, et al.. (1994). Screening of dysfibrinogenaemia using the fibrinogen function versus antigen concentration ratio. Thrombosis Research. 76(6). 577–579. 27 indexed citations
8.
Steiner, Michael, et al.. (1992). Studies and perspectives of plasminogen activators. Biomedical Reviews. 1(0). 33–33. 1 indexed citations
9.
Anders, Olaf. (1966). Entwicklung und Bau des Embryosacks von Streptocarpus rexii. 156(4). 446–451. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nancy Cauwenberghs Breakdown of academic impact, for papers by Taavo Tenno Breakdown of academic impact, for papers by Akinobu Funatsu Breakdown of academic impact, for papers by Henk Louwes Breakdown of academic impact, for papers by Béatrice Saposnik Breakdown of academic impact, for papers by Nathalie Valentin Breakdown of academic impact, for papers by Inge Scharrer Breakdown of academic impact, for papers by Verónica Palma‐Barqueros Breakdown of academic impact, for papers by Seb Lamprecht Breakdown of academic impact, for papers by C Tommasino
Rankless by CCL
2026